Association of A1AT With Poor Functional Outcome in Patients With Acute Ischemic Stroke [PDF]
Background This study aimed to investigate whether A1AT (α‐1 antitrypsin) bloodstream levels, measured acutely after ischemic stroke, can predict the outcome of patients with stroke.
Paula García‐Rodríguez +9 more
doaj +8 more sources
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis [PDF]
Metabolic dysfunction-associated steatohepatitis (MASH) is associated with the activation of Kupffer cells (KCs) and hepatic stellate cells, at which point a metabolically stressed hepatocyte becomes integral to the progression of the disease.
Jeong-Su Park +22 more
doaj +6 more sources
FBG1 Is the Final Arbitrator of A1AT-Z Degradation. [PDF]
Alpha-1 antitrypsin deficiency is the leading cause of childhood liver failure and one of the most common lethal genetic diseases. The disease-causing mutant A1AT-Z fails to fold correctly and accumulates in the endoplasmic reticulum (ER) of the liver ...
John H Wen +3 more
doaj +5 more sources
Altered polyadenylation site usage in SERPINA1 3’UTR in response to cellular stress affects A1AT protein expression [PDF]
Alternative polyadenylation results in different 3’ isoforms of messenger RNA (mRNA) transcripts. Alternative polyadenylation in the 3’ untranslated region (3’UTR) can alter RNA localization, stability and translational efficiency.
F. N. U. Jiamutai +5 more
doaj +3 more sources
The Utilization of Alpha 1 Anti-trypsin (A1AT) in Infectious Disease Monitoring and Treatment.
Alpha one anti-trypsin (A1AT) is a major serine protease inhibitor found circulating in human blood. A1AT related studies mainly focus on A1AT potential biomarker as well as therapeutic target in non-infectious diseases.
Irene Lorinda Indalao +5 more
doaj +5 more sources
Combination of alpha-1 antitrypsin (A1AT) and anti-TNFα as a neuroprotective strategy in the early stages after ischemic stroke. [PDF]
Neuroprotection after ischemic stroke has been focused on targeting one pathway of the ischemic cascade. In this study, we have hypothesized that combination therapy with alpha-1 antitrypsin (A1AT) and a blocker of tumor necrosis factor (TNFα) could be ...
García-Rodríguez P +5 more
europepmc +2 more sources
SUN-574 A1AT: Novel Inhibitor of Active PCSK9
Heart disease is the principal cause of death and disability for both men and women in the US, accounting for 40% of all annual deaths. African American populations are disproportionately burdened with metabolic diseases, due in part to cholesterol ...
Q. Melendez +5 more
semanticscholar +2 more sources
Association of A1AT genetic polymorphism and NSCLC: a case- control study in Egyptian population
Background Lung cancer mortality is higher than other forms of cancer. Genetic tendencies in cancer patients have long been known. Given the link between A1ATD and numerous lung disorders, it is worth investigating if this genetic trait is linked to a ...
Aliaa N. El-Dawa +3 more
semanticscholar +4 more sources
Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency. [PDF]
Alpha-1-antitrypsin deficiency (A1ATD) is a common genetic condition which predisposes to emphysema and liver disorders. It is estimated that 10-15% of homozygous individuals for the Z allele (PiZZ) may develop liver fibrosis. The optimal modalities to detect liver disease in PiZZ adult patients need to be defined. The aim of this prospective study was
O. Guillaud +7 more
semanticscholar +5 more sources
a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm [PDF]
Background Previous proteomic studies have demonstrated the potential for identifying specific diagnostic biomarkers in the plasma and follicular fluid of patients with polycystic ovary syndrome (PCOS), which was utilized to elucidate the underlying ...
Na Li +7 more
doaj +2 more sources

